Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 11

    1.

    A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma.

    Shimoni A, Avivi I, Rowe JM, Yeshurun M, Levi I, Or R, Patachenko P, Avigdor A, Zwas T, Nagler A.

    Cancer. 2012 Jan 17. doi: 10.1002/cncr.27418. [Epub ahead of print]

    PMID:
    22252613
    [PubMed - as supplied by publisher]
    2.

    Circulating endothelial progenitors and CXCR4-positive circulating endothelial cells are predictive markers for bevacizumab.

    Matsusaka S, Mishima Y, Suenaga M, Terui Y, Kuniyoshi R, Mizunuma N, Hatake K.

    Cancer. 2011 Sep 1;117(17):4026-32. doi: 10.1002/cncr.25977. Epub 2011 Feb 24.

    PMID:
    21858803
    [PubMed - indexed for MEDLINE]
    3.

    Formation of solid tumors by a single multinucleated cancer cell.

    Weihua Z, Lin Q, Ramoth AJ, Fan D, Fidler IJ.

    Cancer. 2011 Sep 1;117(17):4092-9. doi: 10.1002/cncr.26021. Epub 2011 Mar 1.

    PMID:
    21365635
    [PubMed - indexed for MEDLINE]
    4.

    Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study.

    Liu W, Feng JQ, Shen XM, Wang HY, Liu Y, Zhou ZT.

    Cancer. 2012 Mar 15;118(6):1693-700. doi: 10.1002/cncr.26483. Epub 2011 Aug 25.

    PMID:
    22009787
    [PubMed - indexed for MEDLINE]
    5.

    Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin.

    Casagrande F, Cocco E, Bellone S, Richter CE, Bellone M, Todeschini P, Siegel E, Varughese J, Arin-Silasi D, Azodi M, Rutherford TJ, Pecorelli S, Schwartz PE, Santin AD.

    Cancer. 2011 Dec 15;117(24):5519-28. doi: 10.1002/cncr.26215. Epub 2011 Jun 20.

    PMID:
    21692061
    [PubMed - indexed for MEDLINE]
    6.

    Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia.

    Guidetti A, Carlo-Stella C, Ruella M, Miceli R, Devizzi L, Locatelli SL, Giacomini A, Testi A, Buttiglieri S, Risso A, Mariani L, Di Nicola M, Passera R, Tarella C, Gianni AM.

    Cancer. 2011 Nov 15;117(22):5074-84. doi: 10.1002/cncr.26182. Epub 2011 May 12.

    PMID:
    21567384
    [PubMed - indexed for MEDLINE]
    7.

    Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma.

    Dietrich S, Tielesch B, Rieger M, Nickelsen M, Pott C, Witzens-Harig M, Kneba M, Schmitz N, Ho AD, Dreger P.

    Cancer. 2011 May 1;117(9):1901-10. doi: 10.1002/cncr.25756. Epub 2010 Nov 29.

    PMID:
    21509767
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27.

    Hsu HS, Lin JH, Huang WC, Hsu TW, Su K, Chiou SH, Tsai YT, Hung SC.

    Cancer. 2011 Apr 1;117(7):1516-28. doi: 10.1002/cncr.25599. Epub 2010 Nov 8.

    PMID:
    21425153
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: Long-Term Follow-Up, Prognostic Factors, and Effect of Human Leukocyte Histocompatibility Antigen Subtype on Outcome.

    Khouri IF, Bassett R, Poindexter N, O'Brien S, Bueso-Ramos CE, Hsu Y, Ferrajoli A, Keating MJ, Champlin R, Fernandez-Vina M.

    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26091. [Epub ahead of print]

    PMID:
    21455998
    [PubMed - as supplied by publisher]
    Free Article
    10.

    Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.

    Juliusson G, Karlsson K, Lazarevic VLj, Wahlin A, Brune M, Antunovic P, Derolf A, Hägglund H, Karbach H, Lehmann S, Möllgård L, Stockelberg D, Hallböök H, Höglund M; Swedish Acute Leukemia Registry Group, the Swedish Acute Myeloid Leukemia Group, the Swedish Adult Acute Lymphoblastic Leukemia Group.

    Cancer. 2011 Sep 15;117(18):4238-46. doi: 10.1002/cncr.26033. Epub 2011 Mar 8.

    PMID:
    21387283
    [PubMed - indexed for MEDLINE]
    11.

    Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.

    Hsu HS, Huang PI, Chang YL, Tzao C, Chen YW, Shih HC, Hung SC, Chen YC, Tseng LM, Chiou SH.

    Cancer. 2011 Jul 1;117(13):2970-85. doi: 10.1002/cncr.25869. Epub 2011 Jan 10.

    PMID:
    21225866
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk